JP6116907B2 - サルカルディン及びその塩の緩速点滴 - Google Patents

サルカルディン及びその塩の緩速点滴 Download PDF

Info

Publication number
JP6116907B2
JP6116907B2 JP2012539070A JP2012539070A JP6116907B2 JP 6116907 B2 JP6116907 B2 JP 6116907B2 JP 2012539070 A JP2012539070 A JP 2012539070A JP 2012539070 A JP2012539070 A JP 2012539070A JP 6116907 B2 JP6116907 B2 JP 6116907B2
Authority
JP
Japan
Prior art keywords
composition
administration
active agent
minutes
sulfate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012539070A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013511472A5 (https=
JP2013511472A (ja
Inventor
ティー． エリオット ゲリー
ティー． エリオット ゲリー
バイ ドングル
バイ ドングル
ワン イッピン
ワン イッピン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Materia Medica of CAS
Original Assignee
Shanghai Institute of Materia Medica of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Materia Medica of CAS filed Critical Shanghai Institute of Materia Medica of CAS
Publication of JP2013511472A publication Critical patent/JP2013511472A/ja
Publication of JP2013511472A5 publication Critical patent/JP2013511472A5/ja
Application granted granted Critical
Publication of JP6116907B2 publication Critical patent/JP6116907B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2012539070A 2009-11-17 2010-11-16 サルカルディン及びその塩の緩速点滴 Active JP6116907B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26192709P 2009-11-17 2009-11-17
US61/261,927 2009-11-17
PCT/US2010/056849 WO2011062903A2 (en) 2009-11-17 2010-11-16 Slow infusion of sulcardine and its salts

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015157843A Division JP6173391B2 (ja) 2009-11-17 2015-08-10 サルカルディン及びその塩の緩速点滴

Publications (3)

Publication Number Publication Date
JP2013511472A JP2013511472A (ja) 2013-04-04
JP2013511472A5 JP2013511472A5 (https=) 2017-02-02
JP6116907B2 true JP6116907B2 (ja) 2017-04-19

Family

ID=44060289

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012539070A Active JP6116907B2 (ja) 2009-11-17 2010-11-16 サルカルディン及びその塩の緩速点滴
JP2015157843A Active JP6173391B2 (ja) 2009-11-17 2015-08-10 サルカルディン及びその塩の緩速点滴

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015157843A Active JP6173391B2 (ja) 2009-11-17 2015-08-10 サルカルディン及びその塩の緩速点滴

Country Status (7)

Country Link
US (1) US8637566B2 (https=)
EP (1) EP2501380B1 (https=)
JP (2) JP6116907B2 (https=)
CN (1) CN102869357A (https=)
ES (1) ES2569123T3 (https=)
PL (1) PL2501380T3 (https=)
WO (1) WO2011062903A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2501381B1 (en) * 2009-11-17 2017-07-26 Huya Bioscience International LLC Treatment of atrial fibrillation
EP2501380B1 (en) * 2009-11-17 2016-01-27 Huya Bioscience International LLC Slow infusion of sulcardine and its salts
CN113453677A (zh) 2018-12-13 2021-09-28 沪亚生物国际有限责任公司 用于治疗急性心房颤动的舒卡定施用
SG11202108160YA (en) * 2019-01-29 2021-08-30 Huya Bioscience International Llc Sulcardine salts
CN112516136B (zh) * 2019-09-17 2024-03-01 中国科学院上海药物研究所 硫酸舒欣啶在制备抗心衰产品中的应用
IL298907A (en) * 2020-06-12 2023-02-01 Huyabio Int Llc Administering sulcardin for the treatment of acute atrial fibrillation
CN114984004B (zh) * 2022-05-25 2023-09-12 扬州中宝药业股份有限公司 硫酸舒欣啶在制备抗脓毒症药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1172908C (zh) * 1999-12-10 2004-10-27 中国科学院上海药物研究所 N-取代苄基或苯基芳香磺酰胺化合物及其用途
EP2501381B1 (en) * 2009-11-17 2017-07-26 Huya Bioscience International LLC Treatment of atrial fibrillation
EP2501380B1 (en) * 2009-11-17 2016-01-27 Huya Bioscience International LLC Slow infusion of sulcardine and its salts

Also Published As

Publication number Publication date
WO2011062903A2 (en) 2011-05-26
US8637566B2 (en) 2014-01-28
ES2569123T3 (es) 2016-05-06
EP2501380A2 (en) 2012-09-26
US20120245214A1 (en) 2012-09-27
WO2011062903A9 (en) 2011-09-09
CN102869357A (zh) 2013-01-09
EP2501380A4 (en) 2013-05-22
JP2013511472A (ja) 2013-04-04
EP2501380B1 (en) 2016-01-27
JP2016014034A (ja) 2016-01-28
JP6173391B2 (ja) 2017-08-02
PL2501380T3 (pl) 2016-08-31

Similar Documents

Publication Publication Date Title
JP6173391B2 (ja) サルカルディン及びその塩の緩速点滴
JP6116908B2 (ja) 心房細動の治療
JP2013511473A5 (https=)
JP2013511472A5 (https=)
JP7087040B2 (ja) ピリジルアミノ酢酸化合物を含む医薬製剤
JP2021181478A (ja) 貧血治療のための組成物及び方法
US8188140B2 (en) Uses of ion channel modulating compounds
US20110166220A1 (en) Dronedarone for the prevention of permanent atrial fibrillation
JP2022514537A (ja) 急性心房細動の処置のためのサルカルディン投与
US20090041841A1 (en) Controlled release tablet formulations for the prevention of arrhythmias
RU2358732C2 (ru) Жидкие фармацевтические композиции, содержащие производные 3,7-диазабицикло(3,3,1)нонана, для лечения антиаритмических реакций
KR20230024347A (ko) 급성 심방 세동의 치료를 위한 설카르딘 투여
HK1254495B (en) Use of sulcardine for the treatment of atrial fibrillation
HK1176859A (en) Treatment of atrial fibrillation
HK1176859B (en) Treatment of atrial fibrillation
HK1176858B (en) Slow infusion of sulcardine and its salts
KR100795313B1 (ko) 암로디핀 베실레이트를 포함하는 약학 조성물
JPS61172820A (ja) カルシウム拮抗剤
EA045624B1 (ru) Введение сулькардина для лечения острой фибрилляции предсердий
Tamargo et al. Class III Antiarrhythmic

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20131015

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20131108

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140108

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140213

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20140213

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20140310

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20140310

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20141128

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150228

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150410

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150821

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150821

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20151013

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151022

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151013

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151225

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20161019

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20161114

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20161216

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170322

R150 Certificate of patent or registration of utility model

Ref document number: 6116907

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250